Cansino Biologics Inc Capital Reinvestment Ratio
Cansino Biologics Inc capital reinvestment ratio. Cansino Biologics Inc (688185) has a Capital Reinvestment Ratio of 1.45x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥30.53 Million) in capital expenditures (CN¥44.23 Million). See 688185 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Cansino Biologics Inc (2021–2025)
Capital reinvestment ratio of Cansino Biologics Inc from 2021 to 2025. This chart tracks Cansino Biologics Inc's Capital Reinvestment Ratio across 2 annual periods. See how financially flexible is Cansino Biologics Inc to measure the company's free cash flow as a share of total liabilities.
Cansino Biologics Inc Capital Reinvestment Ratio by Year (2021–2025)
Cansino Biologics Inc capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see 688185 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.13x | CN¥77.86 Million | CN¥243.90 Million | ▲ +424.5% |
| 2021 | 0.60x | CN¥2.01 Billion | CN¥1.20 Billion | — |